Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of AmericansBusiness Wire • 02/06/26
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026The Motley Fool • 02/04/26
Will the Market Crash in 2026? Here's What History Says and What to Do About ItThe Motley Fool • 02/04/26
Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug DataZacks Investment Research • 02/03/26
Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As EverSeeking Alpha • 02/03/26
Pfizer (PFE) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/03/26
Pfizer Targets Monthly Obesity Shot. Why Lilly Could Still Have The Weight-Loss Heavyweight.Investors Business Daily • 02/03/26
Pfizer says once-a-month weight-loss drug works as it forecasts profit declineMarket Watch • 02/03/26